Medicine’s march toward remote monitoring of patients hit at least a temporary roadblock yesterday.An implanted wireless device intended to continuously monitor patients with weak hearts — and then provide the data to doctors via the Internet — did not keep enough of them out of the hospital to prove its effectiveness, according to a panel of experts assembled by the Food and Drug Administration.
The device’s manufacturer, Medtronic, has been developing wireless data-gathering technology for implanted therapeutic devices like defibrillators and insulin pumps. It aimed to make the product reviewed yesterday, a device the size of a pocket watch and known as the Chronicle implantable hemodynamic monitor, the first major implant approved solely for diagnostic monitoring.
More.
Seemed like it should help...
Medicine Tag
Health Tag
Save This Page
No comments:
Post a Comment